C

Chromocell Therapeutics Corp
AMEX:CHRO

Watchlist Manager
Chromocell Therapeutics Corp
AMEX:CHRO
Watchlist
Price: 22.46 USD -5.03% Market Closed
Market Cap: 3.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CHRO.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CHRO Intrinsic Value
Not Available
Base Case Scenario
Compare CHRO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CHRO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chromocell Therapeutics Corp

Current Assets 911.2k
Cash & Short-Term Investments 131.3k
Other Current Assets 779.9k
Current Liabilities 5.1m
Accounts Payable 2.6m
Short-Term Debt 2.5m
Efficiency

Free Cash Flow Analysis
Chromocell Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Chromocell Therapeutics Corp

Revenue
0 USD
Operating Expenses
-5.3m USD
Operating Income
-5.3m USD
Other Expenses
-244.7k USD
Net Income
-5.6m USD
Fundamental Scores

CHRO Profitability Score
Profitability Due Diligence

Chromocell Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional 3Y Average ROE
Exceptional ROIC
Exceptional ROE
hidden
Profitability
Score

Chromocell Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CHRO Solvency Score
Solvency Due Diligence

Chromocell Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
hidden
Solvency
Score

Chromocell Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CHRO Price Targets Summary
Chromocell Therapeutics Corp

There are no price targets for CHRO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Chromocell Therapeutics Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for CHRO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CHRO Insider Trading
Buy and sell transactions by insiders